Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa…
Exa Platform Konica Minolta Healthcare's Exa® Platform facilitates the viewing of large medical image files across the enterprise. TAMPA, Fla.…
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery…
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team…
Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene…
Regulatory authorization will signal the first electronic technology to detect a disease CLEVELAND, May 20, 2025 /PRNewswire/ -- IdentifySensors Biologics,…
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as…
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first…
--Efficacy comparable to anti-IL4/IL13 antibody control --Achieved dose-dependent and durable target modulation in vivo without requiring degradation of STAT6 protein…
Presented new preclinical data in non-human primates (NHP) for alpha-1 antitrypsin deficiency (AATD) and phenylketonuria (PKU), where RNA Gene Writer…